Latest News - TearLab Corp.

Thursday, January 04, 2018

TearLab Submits 510(k) for FDA Clearance of TearLab Discovery Platform

TearLab announced that it has submitted a 510(k) application to the FDA for the potential clearance of its TearLab Discovery Platform, the company's next-generation in-vitro diagnostic testing sys…

Read the full story

Wednesday, November 08, 2017

Nasdaq to Delist TearLab Tomorrow After failing to Meet Listing Requirements

Citing its failure to meeting listing requirements for minimum market cap and stockholders' equity, Nasdaq has notified TearLab that it will delist its shares at the open tomorrow, November 9. S…

Read the full story

Friday, July 21, 2017

TearLab Announces European Regulatory Clearance for Next-Generation TearLab Discovery System

TearLab announced that the commercial version of its next-generation in-vitro diagnostics testing platform, the TearLab Discovery System, has received CE Marking, providing clearance in the European U…

Read the full story

Friday, October 14, 2016

TearLab and PRN Physician Recommended Nutriceuticals Announce Co-Promotion Agreement

TearLab announced that it has entered into a definitive co-promotion agreement with PRN Physician Recommended Nutriceuticals (PRN), based in Plymouth Meeting, PA, whereby PRN and the company will join…

Read the full story

Thursday, July 14, 2016

TearLab Comments on Shire FDA Approval of Xiidra (Lifitegrast)

TearLab released a statement recognizing Shire on its recent FDA approval of Xiidra (lifitegrast ophthalmic solution) 5% for the treatment of signs and symptoms of dry eye disease (DED). “We …

Read the full story

Thursday, May 05, 2016

TearLab Announces $17.3 Million Public Offering

TearLab announced May 4, 2016, the pricing of a public offering of the company’s common stock, resulting in total gross proceeds of approximately $17.3 million. The offering is expected to close…

Read the full story

Monday, February 29, 2016

TearLab Announces Strategic Restructuring; Job Cuts

TearLab announced a strategic restructuring, including a staff reduction of employees, designed to improve the company’s overall cost structure, extend its cash runway, and shorten the time requ…

Read the full story

Friday, October 09, 2015

Medical Necessity of Tear Osmolarity Testing in the Diagnosis and Management of Dry Eye Disease Confirmed in Recently Published Medicare Local Coverage Determination

TearLab announced that First Coast Service Options (Medicare Area Contractor for Florida, Puerto Rico and the US Virgin Islands) has published a Local Coverage Determination (LCD) that confirms the ro…

Read the full story

Tuesday, July 07, 2015

TearLab Announces Appointment of Wes Brazell as CFO; Relocates Headquarters

TearLab Corporation announced the appointment of Wes Brazell as its chief financial officer, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning,…

Read the full story

Wednesday, January 28, 2015

TearLab Appoints Raymond Kong as Vice President of Sales

TearLab announced the appointment of Raymond Kong to its senior management team as vice president of sales, according to a company news release. Mr. Kong succeeds Duane Morrison, who will shift his fo…

Read the full story